Privi Speciality Chemicals

Privi Speciality Chemicals delivered a strong Q4 FY26 with revenue of ₹725.7 CrCurrent reported value: ₹725.7 Cr. No comparable prior figure is available in the source record. (+15.3Current reported value: 15.3. No comparable prior figure is available in the source record.% YoY) and EBITDA of ₹184.4 CrCurrent reported value: ₹184.4 Cr. No comparable prior figure is available in the source record. (+25.1% YoY), driven by volume growth, price increases, and improved product mix. EBITDA margin expanded to 25.4%Current reported value: 25.4%. No comparable prior figure is available in the source record. (+200 bps YoY) due to cost optimization and operational efficiencies. PAT surged 50.5%Current reported value: 50.5%. No comparable prior figure is available in the source record. to ₹95.7 Cr. For FY26, revenue grew 21.7%Current reported value: 21.7%. No comparable prior figure is available in the source record. to ₹2,582.9 Cr, with EBITDA margin of 25.8%Current reported value: 25.8%. No comparable prior figure is available in the source record.. Management guided for ~20% revenue growth in FY27 with sustained 25Current reported value: 25. No comparable prior figure is available in the source record.%+ EBITDA margins, supported by capacity expansion to 54,000 MT by June 2026 and new specialty products (maltol, cyclopentanone) commercializing by Q1 FY27. The JV with Privi turned profitable in Q4. Key risk: raw material price volatility and supply chain disruptions from geopolitical tensions could pressure margins.